Rising Cancer Cases to boost the Molecular Cytogenetics Market Growth

Molecular Cytogenetics Market

Molecular Cytogenetics Market by Products (Kits & Reagents, Instruments, and Software & Services), Technique (Fluorescence in Situ Hybridization, Comparative Genomic Hybridization, Karyotyping, Other Techniques), Application (Cancer, Genetic Disorders, Other Applications), And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030

The global Molecular Cytogenetics Market is estimated to be valued at US$ 4,211.4 million in 2023, and is expected to exhibit a CAGR of 24.5 % over the forecast period, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Clinical cytogenetics is the examination of the relation between chromosomal alterations and genetic disorders in human beings. Molecular cytogenetics is an examination of genetic diseases utilizing new techniques and methods that link cytogenetic and molecular techniques. Molecular Cytogenetics mainly defines a huge set of the methods that function either with the whole genome or with specific targeted DNA sequences. Topical areas consist Structural and functional arrangement of chromosome and nucleus.

Competitive Landscape:

Key players involved in the growth of global Molecular Cytogenetics Market are Oxford Gene Technology, F.Hoffmann-La Roche Ltd., Abbott Laboratories, Agilent Technologies, Inc., Quest Diagnostics, PerkinElmer Inc, Bio-Rad Laboratories, Inc., Illumina, Inc., and Thermo Fisher Scientific.

Market Key Drivers:

Increasing number of cancer cases and genetic disorders is expected to propel the growth of the global Molecular Cytogenetics Market. For instance, as per WHO, around 20 million people suffer from cancer across the globe in 2023.

The technological developments in molecular cytogenetics is anticipated to boost the growth of global Molecular Cytogenetics Market. For instance, in October 2022, Thermo Fisher Scientific enhanced its Applied Biosystems Chromosome Analysis Suite software by a partnership with Genoox.

Covid-19 Impact Analysis:

The Covid-19 outbreak has significantly affected the growth of the global Molecular Cytogenetics Market. In the pandemic the modification in genetic substances in affected people was detected with the help of cytogenetics. For example, as per Nature journal’s article, genetic factors impelling COVID-19 susceptibility and severity presented new biological insights into disease etiology and detect molecular targets for development of treatment or medication repurposing.

Key Takeaways:

The global Molecular Cytogenetics Market is anticipated to exhibit a CAGR of 24.5 % during the forecast period owing to the rising approvals and product launches. For instance, in May 2022 Pfizer offered a medical approval which assists the global healthcare community’s independent enterprises to increase patient outcomes in fields of unmet clinical necessities that are allied with Pfizer’s medical or scientific plans. 

Among regions, North America, Europe and Asia Pacific are expected to witness robust growth in global Molecular Cytogenetics Market due to increasing mergers and acquisitions, increasing partnerships and collaborations and increasing prevalence of cancer. For instance, as per the Canadian Cancer Society 2022 update, around 233,900 people in Canada were diagnosed with cancer.